rs55872908
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001122752.2(SERPINI1):c.838G>A(p.Ala280Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0162 in 1,613,532 control chromosomes in the GnomAD database, including 272 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001122752.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SERPINI1 | NM_001122752.2 | c.838G>A | p.Ala280Thr | missense_variant | 5/9 | ENST00000446050.7 | NP_001116224.1 | |
SERPINI1 | NM_005025.5 | c.838G>A | p.Ala280Thr | missense_variant | 5/9 | NP_005016.1 | ||
SERPINI1 | XM_017006618.3 | c.838G>A | p.Ala280Thr | missense_variant | 5/9 | XP_016862107.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SERPINI1 | ENST00000446050.7 | c.838G>A | p.Ala280Thr | missense_variant | 5/9 | 1 | NM_001122752.2 | ENSP00000397373 | P1 | |
SERPINI1 | ENST00000295777.9 | c.838G>A | p.Ala280Thr | missense_variant | 5/9 | 1 | ENSP00000295777 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0109 AC: 1652AN: 152062Hom.: 16 Cov.: 32
GnomAD3 exomes AF: 0.0114 AC: 2856AN: 251164Hom.: 27 AF XY: 0.0117 AC XY: 1590AN XY: 135746
GnomAD4 exome AF: 0.0168 AC: 24532AN: 1461352Hom.: 256 Cov.: 32 AF XY: 0.0165 AC XY: 11984AN XY: 726960
GnomAD4 genome AF: 0.0109 AC: 1652AN: 152180Hom.: 16 Cov.: 32 AF XY: 0.0101 AC XY: 754AN XY: 74384
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Dec 17, 2018 | - - |
Familial encephalopathy with neuroserpin inclusion bodies Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
SERPINI1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 05, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at